Remote Oxidation of Aliphatic C–H Bonds in ... - ACS Publications

Nov 4, 2015 - Joseph R. Clark, Louis J. Trzepkowski, and M. Christina White*. Roger Adams Laboratory, Department of Chemistry, University of Illinois,...
6 downloads 0 Views 853KB Size
Subscriber access provided by SICHUAN NORMAL UNIV LIB

Communication

Remote Oxidation of Aliphatic C—H Bonds in Nitrogen Containing Molecules Jennifer M. Howell, Kaibo Feng, Joseph R. Clark, Louis J. Trzepkowski, and M. Christina White J. Am. Chem. Soc., Just Accepted Manuscript • DOI: 10.1021/jacs.5b10299 • Publication Date (Web): 04 Nov 2015 Downloaded from http://pubs.acs.org on November 5, 2015

Just Accepted “Just Accepted” manuscripts have been peer-reviewed and accepted for publication. They are posted online prior to technical editing, formatting for publication and author proofing. The American Chemical Society provides “Just Accepted” as a free service to the research community to expedite the dissemination of scientific material as soon as possible after acceptance. “Just Accepted” manuscripts appear in full in PDF format accompanied by an HTML abstract. “Just Accepted” manuscripts have been fully peer reviewed, but should not be considered the official version of record. They are accessible to all readers and citable by the Digital Object Identifier (DOI®). “Just Accepted” is an optional service offered to authors. Therefore, the “Just Accepted” Web site may not include all articles that will be published in the journal. After a manuscript is technically edited and formatted, it will be removed from the “Just Accepted” Web site and published as an ASAP article. Note that technical editing may introduce minor changes to the manuscript text and/or graphics which could affect content, and all legal disclaimers and ethical guidelines that apply to the journal pertain. ACS cannot be held responsible for errors or consequences arising from the use of information contained in these “Just Accepted” manuscripts.

Journal of the American Chemical Society is published by the American Chemical Society. 1155 Sixteenth Street N.W., Washington, DC 20036 Published by American Chemical Society. Copyright © American Chemical Society. However, no copyright claim is made to original U.S. Government works, or works produced by employees of any Commonwealth realm Crown government in the course of their duties.

Page 1 of 5

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Journal of the American Chemical Society

Remote Oxidation of Aliphatic C—H Bonds in Nitrogen Containing Molecules Jennifer M. Howell‡, Kaibo Feng‡, Joseph R. Clark, Louis J. Trzepkowski and M. Christina White* Roger Adams Laboratory, Department of Chemistry, University of Illinois at Urbana-Champaign, Urbana, Illinois, 61801, United States

Supporting Information Placeholder ABSTRACT: Nitrogen heterocycles are ubiquitous in natu-

ral products and pharmaceuticals. Herein, we disclose a nitrogen complexation strategy that employs a strong Brønsted acid (HBF4) or an azaphilic Lewis acid (BF3) to enable remote, non-directed C(sp3)—H oxidations of tertiary (3°), secondary (2°), and primary (1°) amine- and pyridinecontaining molecules with tunable iron catalysts. Imides resist oxidation and promote remote functionalization.

The development of reactions that selectively oxidize inert C(sp3)—H bonds while tolerating more electron rich nitrogen functionality is a significant, unsolved problem given that nitrogen is ubiquitous in natural products and medicinal agents.1 Among the challenges for developing such reactions are catalyst deactivation via nitrogen binding and direct oxidation of nitrogen to furnish N-oxides. Common electronic deactivation strategies for 2° and 1° amines (e.g. acylation) do not disable hyperconjugative activation leading to functionalization α to the nitrogen (Figure 1).2 Directing group strategies facilitate oxidation of C(sp3)—H bonds that are spatially and geometrically accessible from the directing functional group.3 Remote oxidation of C(sp3)—H bonds in nitrogen-containing molecules is not currently possible with ligated transition metal catalysis. Site-selective and -divergent oxidation of tertiary (3°) and secondary (2°) C—H bonds has been demonstrated with small molecule catalysts, Fe(PDP) 1 and Fe(CF3PDP) 2, respectively.4 Discrimination of C—H bonds can be accomplished via catalyst/substrate electronic, steric and stereoelectronic interactions. Inductive effects within a substrate R N N N

Fe

(SbF 6) 2

α C—H functionalization R' remote

NCMe NCMe

N

H

R

1 Fe((R,R)-PDP); R = H 2 Fe((R,R)-CF 3PDP); R = 2,6-diCF3 Ar

α

H

R"

N R

n

α

R 2N

many examples ref 2

R'

remote C—H functionalization this work Het = piperidine pyridine amine imide

Figure 1. Heterocycle Functionalization

Het

N R

OH R'

n

α

Table 1. Reaction Optimizationa,b Me H Me

N R2 R1

Entry

Method Ad

piperidine 3a-e pyridine 4a-b

Het

Me OH Me

i. Additive ii. Fe(PDP) 1 c oxidation

piperidine 5a-e pyridine 6a-b

Het

N R2 R1

Heterocycle

R1

R2

Additive (equiv)

Yield (%) (rsm) e

3a 4a 3a 3a 3a 3a 4a 4b 3b 3c 3d 3e

Me Me Me Me Me O Boc TFA H H

BF 3

BF 3•OEt 2 (1.1) BF 3•OEt 2 (1.1) HBF 4•OEt 2 (1.1) F 3CCO 2H (1.1) H 2SO 4 (1.1) HBF 4•H 2O (1.1) HBF 4•OEt 2 (1.1) HBF 4•OEt 2 (1.1) -

46 (28) 27 (67) 56 (29) 5 (74) 0 (76) 43 (40) 57 (23) 0 (65) n.d. (37) n.d. (11) 40 (26) 44 (22)

1 2 3 4 5f 6g 7 8a 9a 10 a 11 12 a,h 13 a O

N

O Me H Me

glutarimide 3f

70 (8)

Fe(PDP) 1 c oxidation

O

N

O Me OH Me

glutarimide 5f

O

H H i. HBF 4• OEt 2 ii. Fe(CF3PDP) 2 c oxidation

Me Het

N R

piperidine 3g pyridine 4c

β

Het

Method B i

N R

γ

δ

Me

piperidine 5g pyridine 6c-d

Entry

Heterocycle

R

Yield (%) (rsm) e

Selectivity j

14 15

3g 4c

Me -

57 (4) 53 (10)

1:1 δ/mixture 2.6:1 δ/γ

aIterative

addition (3x): 5 mol% 1, AcOH (0.5 equiv), H 2O 2 (1.2 equiv), MeCN (ref 4a). addition: 25 mol% 2, AcOH (5.0 equiv), H 2O 2 (9.0 equiv), MeCN, syringe pump 6 mL/min (ref 4b,c). cCatalyst enantiomers used interchangeably. dMethod A: (i) Additive (1.1 equiv), CH 2Cl 2, concd in vacuo, (ii) Iterative addition, (iii) 1M NaOH. eIsolated yields, % recovered starting material (rsm). fNo product observed with H 2SO 4 (0.55 equiv). gIn situ addition of HBF 4 (1.1 equiv). h2° Piperidine-BF 3 complex 3e isolated and purifed. Product 5e isolated/purified as 2° piperidine-BF 3 complex. iMethod B: (i) HBF 4•OEt 2 (1.1 equiv), CH 2Cl 2, concd in vacuo, (ii) Slow addition, (iii) 1M NaOH. jBased on isolation. bSlow

strongly influence site-selectivity, as highly electrophilic metal oxidants (e.g. Fe=O) disfavor oxidation of electrondeficient C(sp3)—H bonds. Functionalities with positive charges, such as ammonium cations, or strongly polarized dative bonds, such as amine-borane adducts, exert a strong inductive effect on adjacent C—H bonds.5 We hypothesized that Lewis/Brønsted acid complexation of nitrogen would afford nitrogen tolerance and remote site-selectivity in iron-

ACS Paragon Plus Environment

Journal of the American Chemical Society

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

catalyzed C(sp3)—H oxidations. Herein, we describe strategies that enable remote, non-directed aliphatic C—H oxidation in substrates containing prevalent nitrogen functional groups: amines (3°, 2°, 1°) and pyridines. Imides tolerate oxidative conditions without complexation and promote remote C(sp3)—H oxidation. We evaluated two strategies to effect nitrogen tolerance/remote oxidation: azaphilic, oxidatively stable Lewis acid complexation with boron trifluoride (BF3) and irreversible protonation with tetrafluoroboric acid (HBF4), a strong Brønsted acid with a weakly coordinating counterion. Whereas some precedent exists with these strategies for C— H oxidations,6 olefin oxidations7a-b and metathesis,7c no examples of remote aliphatic C—H oxidations under ligated transition metal catalysis are known. In metal complexes having basic, dative ligands (e.g. PDP), competitive complexation with acid may lead to catalyst deactivation. Exploration of BF3 complexation with both 3° piperidine 3a and pyridine 4a provided encouraging yields of remotely oxidized products (Table 1, entries 1, 2). HBF4 protonation afforded remote oxidation products with improved yields for both 3a and 4a (entries 3, 7). The same protocol with trifluoroacetic acid or sulfuric acid,6c which generate more coordinating counterions, resulted in decreased yield (entry 4, 5). An in situ HBF4 protocol resulted in diminished yield of 5a, suggesting excess acid is not beneficial (entry 6). Oxidation of pyridine N-oxide 4b was unproductive (entry 8).6a Oxidation of acyl-protected piperidines (3b-c, entries 9, 10) resulted in over-oxidized products, likely via Ndealkylation pathways. Both HBF4 protonation and BF3 complexation are effective with 2° piperidine 3d (entries 11, 12). The BF3 complexation strategy is preferable for 2° and 1° amines due to facile purification of oxidized amine-BF3 complexes. Additionally, these complexes can be stored without precaution to exclude atmosphere.8 Despite indiscriminate oxidation of carbamates and amides, we found that imides attenuate nitrogen basicity and enable remote oxidation (entry 13). proximal

Me H distal

Me 2N

H Me

Me 7

Me H

i. HBF4 ii. Fe((R,R)-PDP) 1 oxidation iii. 1M NaOH

51% yield (21% rsm) >20:1 distal/proximal

Me 2N Me 8

(1)

OH Me

Remote methylene oxidation of piperidine 3g and pyridine 4c with Fe(CF3PDP)4c afforded good overall yields but with significantly diminished site-selectivities (Table 1, entries 14, 15). In contrast, Fe(PDP) hydroxylation of remote 3° C—H bonds proceeds with high site-selectivity; no benzylic or methylene oxidation products were detected. HBF4 protonation/oxidation of a linear substrate with competing 3° sites proceeded with excellent selectivity (>20:1 distal/proximal), favoring the site distal from the protonated amine (eq 1). Electron-withdrawing groups (e.g. Br, F, OAc) previously evaluated did not afford such strong inductive deactivation of proximal sites (9:1, 6:1, 5:1 distal/proximal,

Page 2 of 5

Table 2. Basic Aminesa i. complexation ii. Fe(PDP) 1 b or Fe(CF3PDP) 2b

R n

N R

oxidation

9a-n

EtO

Tertiary Piperidinesc

N Me

Me OH Me

N R O

Me OH Me n

O

or

Me OH Me

NC

N Me

10a 52% (28%)

10c 58% (32%)

Me OH Me

R=

EtO

O Me

O N

10e 40% (25%) d,e

Me OH Me

NC

N BF 3 H

Me OH Me

10i 56% (26%) c with HBF 4 43% (22%)h with BF 3

10h 60% (21%) EtO

Me OH

Me OH Me

N H

N BF 3 H

10g 54% (10%)

10f 50% (24%) d 46% (28%) f with Fe(PDP)

N Me

Me

R

Secondary Piperidinesg O

O

10d 50% (41%)

CN

EtO

Me OH Me N Me

10b 55% (20%)

F 3C

N R

10a-n

O

O

O

10j 65% (31%) N BF 3 H

N BF 3 H

Me

n

Me

10k trace (74%)

10l, R=BF 3, 54% (7%)i N 10m, 47% (11%) d R H with HBF 4

Primary Amineg Me F 3B N H H

Me

Fe((S,S)-PDP) 1 oxidation

Me

9n

Me F 3B N H H

Me OH Me

10n 56% (22%)

aIsolated

yield is average of two runs, % rsm in parentheses. bCatalyst enantiomers used interchangeably. cMethod A with HBF 4•Et 2O (1.1 equiv). dMethod B. eStarting material recycled 1x. fMethod B with 1. gMethod A with BF 3•Et 2O (1.1 equiv) concd and purified prior to use. Isolated as BF 3-complex, no NaOH workup. hMethod A with BF 3•Et 2O (1.1 equiv). iMethod B with BF •Et O (1.1 equiv) concd and purified prior to use. Isolated as BF -complex, 3 2 3 no NaOH workup.

Scheme 1. Amine Deprotection Strategies H 2

N H

Me OH Me

20% NaOH

R

1,4-dioxane, rt 90% yield

5d

Me OH Me

n = 1, 2

N BF 3 H

R = H 5e R = CO 2Et 10g

EtO

O

CsF

Me OH Me

MeCN, 85 ºC 95% yield

N H

11

respectively).4a Collectively, these data suggest that Brønsted/Lewis acid complexation renders basic nitrogen a strong inductive withdrawing moiety, enabling remote C— H oxidations often with high site-selectivities. Piperidines substituted at N, C4, and C2 are the most prevalent nitrogen heterocycles in drugs.1a Employing HBF4 protonation, Fe(PDP)-catalyzed tertiary oxidations of Nmethyl or N-alkyl substituted piperidines proceeded uniformly in high yields and with excellent site-selectivities to afford 3° hydroxylated products (Table 2). Notably, piperidine 9a with C2-alkyl substitution was hydroxylated in 52% yield (10a), showcasing the effectiveness of HBF4 protonation in sterically hindered environments. Piperidines with a variety of functional groups (esters, nitriles, electron deficient aromatics) perform well under conditions where competitive hydrolysis or oxidation may occur (10b-f). The 4phenylpiperidine motif in 10d-e represents a pharmacophore found in opioids such as ketobemidone and haloperidol.9 Improved site-selectivities for Fe(CF3PDP)-catalyzed remote methylene oxidations were observed in substrates having more electronic differentiating elements (10e and 10f, 40% and 50%, respectively).

ACS Paragon Plus Environment

Page 3 of 5

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Journal of the American Chemical Society

Analogous 2° piperidine-BF3 complexes worked with equal facility for remote tertiary and secondary oxidations (Table 2). Underscoring the variance in electronics between 3° and 2° C—H bonds, oxidation of 9j delivered 3° alcohol 10j in 65% yield, whereas methylene oxidation of 9k gave trace product. The BF3 complexation strategy is preferred for oxidation of sterically unencumbered 2° and 1° amines (10n), where challenges in product isolation with HBF4 protonation lead to diminished isolated yields (10l vs 10m). Protonation with HBF4 is advantageous in cases where steric hindrance at nitrogen retards effective BF3 coordination (10i 56% and 43% yield, respectively). Hydroxylated amine-BF3 complexes are readily converted to the free amine via basemediated hydrolysis or exposure to a nucleophilic fluoride source (Scheme 1). The latter protocol is advantageous for substrates containing hydrolytically unstable functional groups, such as 10g. Pyridines are the most prevalent heteroaromatic in FDA approved pharmaceuticals.1a Fe(PDP)-catalyzed remote hydroxylation of 3° sites in 2-alkylpyridines proceeded smoothly using HBF4 protonation for both mono- and disubstituted substrates (13a 59%, 13b 61%, Table 3). In these sterically encumbered substrates, complexation with BF3 affords diminished yields (32% and 34%, respectively). Long-chain 3-alkylpyridines, prevalent in natural products,10 are efficiently oxidized (13c 50%). Remote oxidation proceeds in good yields with electron rich pyridines (6a, 13d) whereas yield and mass balance are lower with an electron deficient substrate (13e 34% yield, 29% recovered starting material (rsm)). Pyridines having less electronically favored and exposed 3° sites afford modest site-selectivity (13f 52%, 2.7:1). The one carbon shortened analog of 4-pentylpyridine (4c, Table 1) underwent methylene oxidation with improved site-selectivity (>20:1) but in diminished yield (13g 32% yield). In cyclohexanes4b having bulky, inductive withdrawing substituents, stereoelectronic preference for oxidation at C3 overrides electronic preference for oxidation at C4 (13h 1.6:1 C3/C4 adjusted for number of hydrogens). Imides are abundant in biologically active molecules and serve as synthetic precursors to amines.11 Succinimide 14a and glutarimide 14b were oxidized in excellent yield, without requirement for Brønsted/Lewis acid complexation, to afford the corresponding alcohols (Table 4). Cyclopropyl modified succinimides are tolerated in this C—H oxidation reaction (15c-d). Spirocyclic glutarimide 14f, a substructure in anxiolytic agent buspirone,12 underwent site-selective methylene oxidation in good yield (57%). Analogous to reactivity in enzymatic oxidations,1b we have observed Fe(PDP) to effect both oxidative N-dealkylation of amines and oxidation of electron neutral or rich aromatics. No Ndemethylation was observed with imide 14e (57%) and both 4-nitrophthalimide 14g and unsubstituted phthalimide 14h were oxidized in useful yields (15g 58%; 15h 46%).13 Underscoring the medicinal relevance of this reaction, oxidation of thalidomide analog 14i afforded 15i in good yield

Table 3. Pyridinesa Me H Me n 12a-h

N

i. HBF4 ii. Fe(PDP) 1 b or Fe(CF3PDP) 2b

Me OH Me n

N

oxidation c

O

or

Me

n

13a-h

Me Me OH OH Me R N Me N R = H; 13a 59% (25%) (32% d with BF 3) 13c 50% (30%) R = Me; 13b 61% (23%) (34% d with BF 3) δ Me γ OH Me OH Me Me X X = H; 6a 57% (23%) X = Me; 13d 57% (26%) N X = Cl; 13e 34% (29%) N (+)-13f e 52% (10%), f 2.7:1 γalcohol /δketone g γ Me β

3

O

4 3

N

O

N 13g 32% (24%),h >20:1 γ/β g

13h 42% (5%),h 3.2:1 C3/C4 g,i

aIsolated yield is average of two runs, % rsm in parentheses. bCatalyst enantiomers used interchangeably. cMethod A with HBF 4•Et 2O (1.1 equiv). dMethod B with BF 3•OEt 2 (1.1 equiv), catalyst 1 and 20% NaOH workup. e(+)-13f Refers to pure alcohol. fStarting material recycled 1x. gBased on isolation. hMethod B. i1.6:1 C3/C4 adjusted for number of hydrogens.

Table 4. Imidesa,b O

O

Fe(PDP) 1 c oxidation

R' R N

m

O

14a-i Me OH m Me

O N n

O

n = 1, m = 1; 15a 66% (18%) n = 2, m = 1; 15b 62% (16%)

Me Me OH

R N

m

N R R

O

15f 57% (10%) d

m=3

N X

Me Me OH Me

O Me N O

O

O

O

15a-i

R = H; 15c 64% (15%) R = Me; 15d 60% (16%)

NH

O

n

Me OH Me

O

O

O

or

m n

n

O

O

R N

O

Me OH Me

X = NO 2; 15g 58% (18%) X = H; 15h 46% (17%)

15e 57% (9%) O

O N

N O O Me

m=3

Me OH

thalidomide analog 15i 54% (17%)

aIsolated yield is average of two runs, % rsm in parentheses. bIterative addition. cCatalyst enantiomers used interchangeably. dStarting material recycled 1x.

(54%). Imides are oxidatively stable and inductively deactivating motifs that promote remote oxidations. We evaluated efficacy of the aforementioned nitrogen protection strategies paired with Fe(PDP) or Fe(CF3PDP) oxidation in late-stage diversification of medicinally important complex molecules. Dextromethorphan, an antitussive drug of the morphinan class, contains a basic N-methyl piperidine moiety, an aromatic ring and a benzylic site, all highly prone to oxidation (Scheme 2A). We hypothesized that benzylic deactivation would result from the proximally fused tertiary piperidine, which as its ammonium BF4 salt would be rendered a strong inductive withdrawing group. Exposure of 16 to HBF4 protonation/Fe((S,S)-CF3PDP) oxidation afforded remote, non-benzylic oxidation products, ketone 17 and alcohol 18 in 45% yield with preference for the least sterically hindered methylene site (2.5:1 ketone/alcohol). Abiraterone acetate, having a C17-(3-pyridyl) motif, is a steroidal antiandrogen used in the treatment of prostate cancer. Despite a strong preference for oxidation at 3° benzylic sites (BDE~83 kcal/mol),14 exposure of 19 to HBF4 protonation/Fe((R,R)-CF3PDP) oxidation resulted in a siteselective remote oxidation at C6 (BDE~98 kcal/mol) of the steroid core in 42% yield (6:1 alcohol/ketone) (Scheme 2B).

ACS Paragon Plus Environment

Journal of the American Chemical Society

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 4 of 5

Scheme 2. Late-Stage Functionalization of Nitrogen Containing Molecules a TfO

A.

B.

O

C. N

Dextromethorphan Derivative (+)-16 b

H

N

Me

Me

H AcO

TfO

TfO

N Me

H

H

(+)-17 45% yieldc 2.5:1 ketone/alcohol d

HBF 4 Fe((R,R)-CF3PDP) 2 oxidation

Abiraterone Acetate Analog (+)-19 b

H HO

Me

H

AcO

(+)-20e 42% yieldf,g H OH 6:1 alcohol/ketoned

Cycloheximide Derivative (+)-21, b R = C(O)CH 2Cl

O O Me

H

NH

Fe((S,S)-PDP) 1 oxidation

N

H

OR

O

Me

Me Me

N

(+)-18

H

H

+

O

Me

Me

HBF 4 Fe((S,S)-CF3PDP) 2 oxidation

H

O

H

OR

NH O

Streptovitacin A, R = H; 22 OH R = C(O)CH 2Cl; (+)-23 Me 50% yieldh

aIsolated yield is average of two runs. bSubstrates containing chirality demonstrated matched/mis-matched reactivity with catalyst enantiomers. c(i) HBF •Et O (1.1 equiv), CH Cl , concd in vacuo, (ii) Slow addition with 2, (iii) 1M 4 2 2 2 NaOH. dBased on isolation. e(+)-20 Refers to pure alcohol. f(i) HBF 4•Et 2O (1.1 equiv), CH 2Cl 2, concd in vacuo, (ii) Iterative addition with 2, (iii) NaHCO 3. gStarting material recycled 2x. hIterative addition with 1.

These represent the first examples of transition metal catalyzed remote, aliphatic C—H oxidations on a morphinan and nitrogen-containing steroid skeletons. Cycloheximide, a readily available natural product with broad antimicrobial activity but high toxicity is currently used as a protein synthesis inhibitor. The C4 hydroxylated analogue, streptovitacin A 22, has shown diminished toxicity and has been obtained via an eight step de novo synthesis proceeding in 7% overall yield.15 The direct oxidation of cycloheximide derivative 21 with Fe((S,S)-PDP) affords streptovitacin A derivative 23 in excellent yield (50%) (Scheme 2C), underscoring the power of remote late stage C—H oxidation to streamline synthesis. We have demonstrated remote Fe(PDP)-catalyzed oxidation in a range of nitrogen heterocycles by employing Brønsted/Lewis acid complexation strategies. We envision this will be a highly enabling methodology for the generation of medicinal agents via late-stage oxidation and for the evaluation of their metabolites. ASSOCIATED CONTENT Supporting Information. This material is available free of charge via the Internet at http://pubs.acs.org.

AUTHOR INFORMATION Corresponding Author

[email protected] Author Contributions

‡These authors contributed equally. Funding Sources

Financial support was provided by the NIH/NIGMS (GM 112492).

ACKNOWLEDGMENT We thank G. Snapper for initial investigations, J. Griffin, J. Zhao and T. Osberger for spectra inspection, C. Delaney for checking procedures, Dr. L. Zhu for assistance with NMR data analysis, Dr. J. Bertke and Dr. D. Gray for crystallographic data and analysis. We thank Zoetis for an unrestricted grant to explore C—H oxidations in pharmaceuticals.

REFERENCES (1) (a) Vitaku, E.; Smith, D. T.; Njardarson, J. T. J. Med. Chem. 2014, 57, 10257. (b) White, M. C. Science 2012, 335, 807. (c) Nam, W.; Lee, Y.-M.; Fukuzumi, S. Acc. Chem. Res. 2014, 47, 1146. (2) (a) Campos, K. R. Chem. Soc. Rev. 2007, 36, 1069. (b) Catino, A. J.; Nichols, J. M.; Nettles, B. J.; Doyle, M. P. J. Am. Chem. Soc. 2006, 128, 5648. (c) Condie, A. G.; González-Gómez, J. C.; Stephenson, C. R. J. J. Am. Chem. Soc. 2010, 132, 1464. (d) Hari, D. P.; König, B. Org. Lett. 2011, 13, 3852. (e) Noble, A.; MacMillan, D. W. C. J. Am. Chem. Soc. 2014, 136, 11602. (f) He, J.; Hamann, L. G.; Davies, H. M. L.; Beckwith, R. E. J. Nat. Commun. 2015, 6, 5943. (3) (a) McNally, A.; Haffemayer, B.; Collins, B. S. L.; Gaunt, M. J. Nature 2014, 510, 129. (b) Chan, K. S. L.; Wasa, M.; Chu, L.; Laforteza, B. N.; Miura, M.; Yu, J.-Q. Nat. Chem. 2014, 6, 146. (4) (a) Chen, M. S.; White, M. C. Science 2007, 318, 783. (b) Chen, M. S.; White, M. C. Science 2010, 327, 566. (c) Gormisky, P. E.; White, M. C. J. Am. Chem. Soc. 2013, 135, 14052. (5) (a) Anslyn, E. V.; Dougherty, D. A. Modern Physical Organic Chemistry; University Science Books: California, 2006; pp 15-16. (b) Staubitz, A.; Robertson, A. P. M.; Sloan, M. E.; Manners, I. Chem. Rev. 2010, 110, 4023. (6) Pyridines in Pd(II)/sulfoxide allylic C—H oxidation: (a) Malik, H. A.; Taylor, B. L. H.; Kerrigan, J. R.; Grob, J. E.; Houk, K. N.; Du Bois, J.; Hamann, L. G.; Patterson, A. W. Chem. Sci. 2014, 5, 2352. Aliphatic amines with methyl(trifluoromethyl) dioxirane (TFDO): (b) Asensio, G.; González-Núñez, M. E.; Bernardini, C. B.; Mello, R.; Adam, W. J. Am. Chem. Soc. 1993, 115, 7250. Shilov oxidation of aliphatic amines (5 equiv): (c) Lee, M.; Sanford, M. S. J. Am. Chem. Soc. 2015, 137, 12796. (7) (a) Ferrer, M.; Sánchez-Baeza F.; Messeguer, A.; Diez, A.; Rubiralta, M. J. Chem. Soc., Chem. Commun. 1995, 293. (b) Brennan, M. B.; Claridge, T. D. W.; Compton, R. G.; Davies, S. G.; Fletcher, A. M.; Henstridge, M. C.; Hewings, D. S.; Kurosawa, W.; Lee, J. A.; Roberts, P. M.; Schoonen, A. K.; Thomson, J. E. J. Org. Chem. 2012, 77, 7241. (c) Woodward, C. P.; Spiccia, N. D.; Jackson, W. R.; Robinson, A. J. Chem. Commun. 2011, 47, 779. (8) Hampe, E. M.; Rudkevich, D. M. Tetrahedron 2003, 59, 9619. (9) Zimmerman, D. M.; Nickander, R.; Horng, J. S.; Wong, D. T. Nature 1978, 275, 332. (10) O’Hagan, D. Nat. Prod. Rep. 1997, 14, 637. (11) Gören, M. Z.; Onat, F. CNS Drug Rev. 2007 , 13, 224. (12) Wu, Y.-H.; Rayburn, J. W.; Allen, L. E.; Ferguson, H. C.; Kissel, J. W. J. Med. Chem. 1972, 15, 477. (13) Schmidt, V. A.; Quinn, R. K.; Brusoe, A. T.; Alexanian, E. J. J. Am. Chem. Soc. 2014, 136, 14389. (14) Luo, Y.-R.; Cheng, J.-P. in CRC Handbook of Chemistry & Physics 94th Ed. (ed. Haynes, W. M.) pp. 9-65 (CRC, 2013). (15) Kondo, H.; Oritani, T.; Yamashita, K. Agric. Biol. Chem. 1990, 54, 1531.

ACS Paragon Plus Environment

Page 5 of 5

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Journal of the American Chemical Society N

Fe(PDP) remote C—H oxidation

Me Me H AcO

H

H

Het

H

N Me

N H BF 4

Me

H

H

H Het = piperidine, pyridine AcO amine (1º, 2º, 3º) imide (direct oxidation)

39 examples, avg. 53% yield

ACS Paragon Plus Environment

H

OH

H